Verax Biomedical Secures $6,831,992 New Funding Round

  • Feed Type
  • Date
    8/1/2013
  • Company Name
    Verax Biomedical
  • Mailing Address
    148 Bartlett Street Marlborough, MA 01752
  • Company Description
    Verax Biomedical is a leader in the development of rapid tests designed to detect a broad range of bacterial contaminants based upon its proprietary Pan Genera Detection (PGD) technology.
  • Website
    http://www.veraxbiomedical.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $6,831,992
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.